SK Life Science

Fair Lawn, United States Founded: 1993 • Age: 33 yrs
Develops pharmaceutical treatments for central nervous system disorders and oncology.

About SK Life Science

SK Life Science is a Healthcare company based in Fair Lawn (United States) founded in 1993. It develops pharmaceutical treatments for central nervous system disorders and oncology. It operates on a B2B model. The company has 250 employees. SK Life Science offers products and services including Medicines and Clinical Trials. Its focus areas include Biopharmaceuticals, CNS Treatments and Disorder Therapies. Its legal entity is SK Life Science, Inc. Its competitors include Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical; 3 of its 3 listed competitors have raised funding.

Company details

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals, focuses on innovating treatments for central nervous system disorders and oncology via clinical trials and RD. The company operates from Paramus, New Jersey, USA, providing medicines and medical information to healthcare providers and partners. It emphasizes ethical compliance and global patient safety in its activities, aiming to address unmet medical needs through partnerships and trials.

  • Headquarters Fair Lawn, United States
  • Employees 250
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website sklifescienceinc.com
  • Social LinkedIn X
  • Legal Name Sk Life Science, Inc.
Key Metrics
  • Latest Funding Round
    $316.88K (USD), Grant

    Jan 2009

  • Investors
  • Employee Count
    250

Products & Services of SK Life Science

SK Life Science offers a comprehensive portfolio of products and services, including Medicines and Clinical Trials.

Medicines
Pharmaceuticals

Treatments for CNS disorders and cancer care

Clinical Trials
Research Services

Programs for testing new CNS and oncology treatments

Funding Insights of SK Life Science

  • Total Rounds 2
  • Last Round Grant — $316,876
  • First Round $1.32M

    (Sep 2008)

  • Investors Count 1

All 2 funding rounds of SK Life Science with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2009$316,876Grant––
Sep 2008$1.32MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in SK Life Science

SK Life Science has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for SK Life Science

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of SK Life Science

3 dated milestones of SK Life Science across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded SK Life Science is founded.
  2. Funding First funding round of $1.3M.
  3. Funding Latest funding round, Grant, of $317K.

Competitors of SK Life Science

SK Life Science has 3 listed competitors in our database, 3 of them funded. They include Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
neurocrine.com1992San Diego, United States$10M1,400
Developer of small molecule therapeutics for endocrine and CNS disorders
ptcbio.com1998South Plainfield, United States$248.1M995
Small molecule drugs for rare diseases are developed.
biohavenpharma.com2014New Haven, United States$84.1M932
Therapies for neurological and neuropsychiatric diseases are developed.
Premium access

Detailed competitors of SK Life Science

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of SK Life Science

Websites that share an audience with SK Life Science (sklifescienceinc.com).

Similar websites

Websites whose visitors overlap most with SK Life Science. Affinity shows how closely the audiences match.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as SK Life Science (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sk Life Science

Premium access

Complete news archive for SK Life Science

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SK Life Science

SK Life Science was founded in 1993 and raised its 1st funding round 15 years after it was founded.

SK Life Science is headquartered in Fair Lawn, United States. It is registered at Fair Lawn, New Jersey, United States.

SK Life Science has 250 employees.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals, focuses on innovating treatments for central nervous system disorders and oncology via clinical trials and RD. The company operates from Paramus, New Jersey, USA, providing medicines and medical information to healthcare providers and partners. It emphasizes ethical compliance and global patient safety in its activities, aiming to address unmet medical needs through partnerships and trials.

SK Life Science's top competitors include PTC Therapeutics, Neurocrine and Biohaven Pharmaceutical.

SK Life Science offers Medicines and Clinical Trials.

SK Life Science has 1 investor. Key investors include HHS.

SK Life Science operates through Sk Life Science, Inc..

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available